The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis.

X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene encoding a peroxisomal ABC transporter. In this review, we compare estimates of incidence derived from different populations in order to provide an overview of the worldwide incidence of X-ALD. X-ALD presents with heterogeneous phenotypes ranging from adrenomyeloneuropathy (AMN) to inflammatory demyelinating cerebral ALD (CALD). A large number of different mutations has been described, providing a unique opportunity for analysis of functional domains within ABC transporters. Yet the molecular basis for the heterogeneity of clinical symptoms is still largely unresolved, as no correlation between genotype and phenotype exists in X-ALD. Beyond ABCD1, environmental triggers and other genetic factors have been suggested as modifiers of the disease course. Here, we summarize the findings of numerous reports that aimed at identifying modifier genes in X-ALD and discuss potential problems and future approaches to address this issue. Different options for prenatal diagnosis are summarized, and potential pitfalls when applying next-generation sequencing approaches are discussed. Recently, the measurement of very long-chain fatty acids in lysophosphatidylcholine for the identification of peroxisomal disorders was included in newborn screening programs.

[1]  G. Raymond,et al.  Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines. , 2015, Molecular genetics and metabolism.

[2]  M. Abdelnoor,et al.  Age-dependent penetrance among females with X-linked adrenoleukodystrophy. , 2015, Brain : a journal of neurology.

[3]  A. Moser,et al.  A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. , 2015, Human molecular genetics.

[4]  A. Moser,et al.  Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy. , 2015, Molecular genetics and metabolism.

[5]  B. Poll-The,et al.  Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study , 2015, Journal of Inherited Metabolic Disease.

[6]  M. Engelen,et al.  Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy , 2014, Neurology.

[7]  H. Werner,et al.  Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice , 2014, PloS one.

[8]  Yong Duan,et al.  Exome sequencing identifies mutations in ABCD1 and DACH2 in two brothers with a distinct phenotype , 2014, BMC Medical Genetics.

[9]  S. Kahraman,et al.  Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. , 2014, Reproductive biomedicine online.

[10]  B. Poll-The,et al.  X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment , 2014, Current Neurology and Neuroscience Reports.

[11]  S. Hewson,et al.  Late-onset Zellweger spectrum disorder caused by PEX6 mutations mimicking X-linked adrenoleukodystrophy. , 2014, Pediatric neurology.

[12]  R. Wanders,et al.  Structure-Function Analysis of Peroxisomal ATP-binding Cassette Transporters Using Chimeric Dimers* , 2014, The Journal of Biological Chemistry.

[13]  Zhiye Chen,et al.  Adult cerebral adrenoleukodystrophy and Addison's disease in a female carrier. , 2014, Gene.

[14]  H. Waterham,et al.  A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. , 2014, Biochimica et biophysica acta.

[15]  R. Wanders,et al.  X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. , 2014, Brain : a journal of neurology.

[16]  F. Eichler,et al.  Pathophysiology of X-linked adrenoleukodystrophy☆ , 2014, Biochimie.

[17]  P. Schestatsky,et al.  Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics , 2014, Orphanet Journal of Rare Diseases.

[18]  H. Stockinger,et al.  X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes , 2013, Human molecular genetics.

[19]  A. Moser,et al.  Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible. , 2014, Molecular genetics and metabolism.

[20]  K. Claes,et al.  Dealing with pseudogenes in molecular diagnostics in the next-generation sequencing era. , 2014, Methods in molecular biology.

[21]  K. Xia,et al.  Exome sequencing released a case of X-linked adrenoleukodystrophy mimicking recessive hereditary spastic paraplegia. , 2013, European journal of medical genetics.

[22]  D. Matern,et al.  Newborn screening for lysosomal storage disorders and other neuronopathic conditions. , 2013, Developmental disabilities research reviews.

[23]  C. Wiesinger,et al.  Impaired Very Long-chain Acyl-CoA β-Oxidation in Human X-linked Adrenoleukodystrophy Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction* , 2013, The Journal of Biological Chemistry.

[24]  Rodrigo Lopez,et al.  Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..

[25]  M. Abdelnoor,et al.  Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance. , 2013, Pediatric neurology.

[26]  F. Lan,et al.  Familial Skewed X Chromosome Inactivation in Adrenoleukodystrophy Manifesting Heterozygotes from a Chinese Pedigree , 2013, PloS one.

[27]  N. Shimozawa,et al.  A Novel Double Mutation in the ABCD1 Gene in a Patient with X-linked Adrenoleukodystrophy: Analysis of the Stability and Function of the Mutant ABCD1 Protein. , 2013, JIMD reports.

[28]  S. Cederbaum,et al.  Peanut consumption increases levels of plasma very long chain fatty acids in humans. , 2012, Molecular genetics and metabolism.

[29]  M. Morita,et al.  Peroxisomal ABC transporters: structure, function and role in disease. , 2012, Biochimica et Biophysica Acta.

[30]  S. Kemp,et al.  See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication X-linked Blockinadrenoleukodystrophy: Blockinclinical, Metabolic, Blockingenetic Blockinand Blockinpathophysiological Aspects Article Blockin Blockinin Blockin Blockinbiochimica B , 2022 .

[31]  V. D. De Jesús,et al.  Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[32]  B. Poll-The,et al.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012, Orphanet Journal of Rare Diseases.

[33]  C. Kim,et al.  Mutations, Clinical Findings and Survival Estimates in South American Patients with X-Linked Adrenoleukodystrophy , 2012, PloS one.

[34]  A. Moser,et al.  Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy. , 2012, Molecular genetics and metabolism.

[35]  G. Raymond,et al.  Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated. , 2012, Molecular genetics and metabolism.

[36]  B. Castellotti,et al.  Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms , 2012, Orphanet Journal of Rare Diseases.

[37]  A. Sabbagh,et al.  CD1 Gene Polymorphisms and Phenotypic Variability in X-Linked Adrenoleukodystrophy , 2012, PloS one.

[38]  D. Avramopoulos,et al.  SOD2 as a potential modifier of X-linked adrenoleukodystrophy clinical phenotypes , 2012, Journal of Neurology.

[39]  H. Waterham,et al.  X‐linked adrenomyeloneuropathy due to a novel missense mutation in the ABCD1 start codon presenting as demyelinating neuropathy , 2011, Journal of the peripheral nervous system : JPNS.

[40]  A. Moser,et al.  X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism. , 2011, Molecular genetics and metabolism.

[41]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[42]  S. Baldwin,et al.  Conservation of targeting but divergence in function and quality control of peroxisomal ABC transporters: an analysis using cross-kingdom expression. , 2011, The Biochemical journal.

[43]  X. Bao,et al.  [Association of genetic polymorphisms in methionine metabolism genes with X-linked adrenoleukodystrophy]. , 2011, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[44]  S. Ferdinandusse,et al.  Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene , 2011, Orphanet journal of rare diseases.

[45]  J. Tolar,et al.  Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison’s disease improves survival and neurological outcomes , 2011, European Journal of Pediatrics.

[46]  E. Génin,et al.  Substrate Specificity Overlap and Interaction between Adrenoleukodystrophy Protein (ALDP/ABCD1) and Adrenoleukodystrophy-related Protein (ALDRP/ABCD2)* , 2011, The Journal of Biological Chemistry.

[47]  Jian Zeng,et al.  A rapid and sensitive protocol for prenatal molecular diagnosis of X-linked adrenoleukodystrophy. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[48]  H. Waterham,et al.  Mutations in PEX10 are a cause of autosomal recessive ataxia , 2010, Annals of neurology.

[49]  T. Matsukawa,et al.  Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes , 2010, neurogenetics.

[50]  P. Stankiewicz,et al.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.

[51]  C. Vargas,et al.  X-linked adrenoleukodystrophy: Clinical course and minimal incidence in South Brazil , 2010, Brain and Development.

[52]  R. Wanders,et al.  The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.

[53]  P. Aubourg,et al.  Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X‐Linked Adrenoleukodystrophy , 2009, Brain pathology.

[54]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[55]  A. Moser,et al.  Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. , 2009, Molecular genetics and metabolism.

[56]  M. Weller,et al.  Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample , 2009, Journal of Neurology.

[57]  F. Eichler,et al.  Case records of the Massachusetts General Hospital. Case 1-2009. A 57-year-old man with progressive cognitive decline. , 2009, The New England journal of medicine.

[58]  A. Holzinger,et al.  X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype. , 2008, Biochemical and biophysical research communications.

[59]  H. Waterham,et al.  The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  C. Giménez,et al.  Pregnancy outcome after preimplantation genetic diagnosis in an affected couple with X-linked adrenoleukodystrophy. , 2008, Fertility and sterility.

[61]  F. Galán,et al.  Preimplantation genetic diagnosis of X-linked adrenoleukodystrophy with gender determination using multiple displacement amplification. , 2007, Fertility and sterility.

[62]  F. Wouters,et al.  Live Cell FRET Microscopy , 2007, Journal of Biological Chemistry.

[63]  H. Bernheimer,et al.  Diagnosis of X-linked adrenoleukodystrophy in blood leukocytes. , 2007, Clinical biochemistry.

[64]  Yuehua Zhang,et al.  [Prenatal diagnosis of X-linked adrenoleukodystrophy]. , 2007, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[65]  P. Traubner,et al.  Adrenoleukodystrophy--a new mutation identified. , 2007, Bratislavske lekarske listy.

[66]  J. Gärtner,et al.  X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. , 2006, Biochimica et biophysica acta.

[67]  K. Fliessbach,et al.  The cystathionine beta‐synthase variant c.844_845ins68 protects against CNS demyelination in X‐linked adrenoleukodystrophy , 2006, Human mutation.

[68]  R. Wanders,et al.  Omega-oxidation of very long-chain fatty acids in human liver microsomes. Implications for X-linked adrenoleukodystrophy. , 2006, The Journal of biological chemistry.

[69]  K. Fliessbach,et al.  Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy , 2006, Neurology.

[70]  Stephan Lorenzen,et al.  Function of the PEX19-binding Site of Human Adrenoleukodystrophy Protein as Targeting Motif in Man and Yeast , 2005, Journal of Biological Chemistry.

[71]  A. Moser,et al.  Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. , 2005, Human molecular genetics.

[72]  C. Camps,et al.  X‐linked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative females , 2005, Clinical genetics.

[73]  H. Moser,et al.  Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. , 2005, The Journal of pediatrics.

[74]  H. Moser Adrenoleukodystrophy: phenotypic variability and implications for therapy , 1992, Journal of Inherited Metabolic Disease.

[75]  J. Mandel,et al.  Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. , 2004, Human molecular genetics.

[76]  Carla P. Guimarães,et al.  Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. , 2004, Biochimica et biophysica acta.

[77]  H. Moser,et al.  Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. , 2004, Blood.

[78]  J. Pevsner,et al.  X-Linked Adrenoleukodystrophy: Genes, Mutations, and Phenotypes , 2004, Neurochemical Research.

[79]  E. Bertini,et al.  X-linked adrenoleukodystrophy: first report of the Italian Study Group , 1998, The Italian Journal of Neurological Sciences.

[80]  P. Vreken,et al.  X-linked adrenoleukodystrophy: Improved prenatal diagnosis using both biochemical and immunological methods , 1998, Journal of Inherited Metabolic Disease.

[81]  S. Rechitsky,et al.  Preimplantation genetic diagnosis with HLA matching. , 2004, Reproductive biomedicine online.

[82]  A. Munnich,et al.  Single cell co-amplification of polymorphic markers for the indirect preimplantation genetic diagnosis of hemophilia A, X-linked adrenoleukodystrophy, X-linked hydrocephalus and incontinentia pigmenti loci on Xq28 , 2004, Human Genetics.

[83]  R. Wanders,et al.  Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders , 2003, Brain and Development.

[84]  R. Wanders,et al.  Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. , 2003, Molecular genetics and metabolism.

[85]  T. Klockgether,et al.  Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy , 2003, Journal of Neuroimmunology.

[86]  M. Wichers,et al.  Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation , 2002, Annals of neurology.

[87]  S. Tsuji,et al.  Epidemiology of X-linked adrenoleukodystrophy in Japan , 2002, Journal of Human Genetics.

[88]  T. Amachi,et al.  ATP Binding/Hydrolysis by and Phosphorylation of Peroxisomal ATP-binding Cassette Proteins PMP70 (ABCD3) and Adrenoleukodystrophy Protein (ABCD1)* , 2002, The Journal of Biological Chemistry.

[89]  H. Moser,et al.  Cerebral X‐linked adrenoleukodystrophy in a girl with Xq27‐Ter deletion , 2002, Annals of neurology.

[90]  Carla P. Guimarães,et al.  Molecular characterization of 21 X-ALD Portuguese families: identification of eight novel mutations in the ABCD1 gene. , 2002, Molecular genetics and metabolism.

[91]  G. O'neill,et al.  ABCD1 translation–initiator mutation demonstrates genotype–phenotype correlation for AMN , 2001, Neurology.

[92]  H. Moser,et al.  ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations , 2001, Human mutation.

[93]  Carla P. Guimarães,et al.  Characterisation of two mutations in the ABCD1 gene leading to low levels of normal ALDP , 2001, Human Genetics.

[94]  J. Zeman,et al.  Eight novel ABCD1 gene mutations and three polymorphisms in patients with X‐linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange , 2001, Human mutation.

[95]  H. Moser,et al.  Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening , 2001, Annals of neurology.

[96]  H. Moser,et al.  Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy , 2001, Annals of neurology.

[97]  G. Uziel,et al.  Myelin oligodendrocyte glycoprotein (MOG) polymorphisms and adrenoleukodystrophy , 2000, Journal of Neuroimmunology.

[98]  J. Berger,et al.  Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy. , 2000, Human molecular genetics.

[99]  R. Benarous,et al.  Homo- and Heterodimerization of Peroxisomal ATP-binding Cassette Half-transporters* , 1999, The Journal of Biological Chemistry.

[100]  A. Holzinger,et al.  The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression. , 1999, European journal of biochemistry.

[101]  A. Holzinger,et al.  Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. , 1999, Human molecular genetics.

[102]  Andreas Holzinger,et al.  Prenatal diagnosis of X‐linked adrenoleukodystrophy combining biochemical, immunocytochemical and DNA analyses , 1999, Prenatal diagnosis.

[103]  H. Moser,et al.  Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. , 1999, Molecular genetics and metabolism.

[104]  H. Moser,et al.  Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.

[105]  A. Moser,et al.  Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy , 1998, Nature Medicine.

[106]  A. Poulos,et al.  X-linked adrenoleukodystrophy: the Australasian experience. , 1998, American journal of medical genetics.

[107]  J. Mandel,et al.  Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines. , 1998, European journal of cell biology.

[108]  A. Moser,et al.  Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. , 1998, Human molecular genetics.

[109]  J. Gärtner,et al.  Leukodystrophy incidence in Germany. , 1997, American journal of medical genetics.

[110]  E. Eichler,et al.  Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. , 1997, Human molecular genetics.

[111]  K. Smith,et al.  Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis , 1997, Journal of Neuroimmunology.

[112]  J. Mandel,et al.  Adrénoleucodystrophie liée à l'X , 2007 .

[113]  F. Hanefeld,et al.  Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype , 1996, Annals of neurology.

[114]  A. Roscher,et al.  Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles. , 1995, Biochemical and biophysical research communications.

[115]  H. Moser,et al.  Tumor necrosis factor-α and X-linked adrenoleukodystrophy , 1995, Journal of Neuroimmunology.

[116]  R. Schutgens,et al.  A misdiagnosis of X‐linked adrenoleucodystrophy in cultured chorionic villus cells by the measurement of very long chain fatty acids , 1995 .

[117]  I. Faé,et al.  X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. , 1994, Biochemical and biophysical research communications.

[118]  G. Weverling,et al.  Predominance of the adrenomyeloneuropathy phenotype of X‐linked adrenoleukody strophy in the Netherlands , 1994, Neurology.

[119]  A. Poulos,et al.  Pitfalls in the prenatal diagnosis of peroxisomal β‐oxidation defects by chorionic villus sampling , 1994, Prenatal diagnosis.

[120]  D. Housman,et al.  Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. , 1994, American journal of medical genetics.

[121]  T. Hashimoto,et al.  Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. , 1994, American journal of human genetics.

[122]  E. Watkiss,et al.  Is skewed X inactivation responsible for symptoms in female carriers for adrenoleucodystrophy? , 1993, Journal of medical genetics.

[123]  R. Wanders,et al.  Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. , 1993, Clinical chemistry.

[124]  Jean Mosser,et al.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.

[125]  N. Baumann,et al.  Adrenoleukodystrophy in France: an epidemiological study. , 1993, Neuroepidemiology.

[126]  A. H. Handyside,et al.  Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification , 1990, Nature.

[127]  H. Moser,et al.  Adrenoleukodystrophy , 1998, Neurology.

[128]  B. Migeon,et al.  Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.